Jagsonpal Pharmaceuticals has informed that 42nd Annual General Meeting (‘AGM’) of the Company is scheduled to be held on Thursday, September 30, 2021, at 11:00 am (IST) through Video Conferencing/ Other Audio-Visual Means. The Annual Report for the financial year 2020-21 of the 42nd AGM of the Company will be sent to all the members whose email addresses are registered with the Company/ Depository Participants and will also be available on the Company's website at www.jagsonpal.com in due course. The company has enclosed copies of the newspaper advertisements published on September 07, 2021, in ‘Business Standard’ (English) and ‘Business Standard’ (Hindi) pursuant to General Circular No. 20/2020 dated May 5, 2020 issued by the Ministry of Corporate Affairs.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1850.40 |
| Dr. Reddys Lab | 1310.50 |
| Cipla | 1365.25 |
| Zydus Lifesciences | 939.10 |
| Lupin | 2442.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: